BEAT

HeartBeam, Inc. is a medical technology company focused on transforming cardiac care through its proprietary vectorelectrocardiography (VECG) technology platform. Based in Santa Clara, California, HeartBeam is developing the first and only credit card-sized, cable-free, 12-lead output ECG device coupled with cloud-based diagnostic software algorithms. The company's innovative approach aims to enable patients to capture diagnostic-quality heart attack detection ECGs anytime, anywhere, and send them to physicians for rapid analysis, potentially revolutionizing the detection and management of acute coronary syndrome. HeartBeam's lead product, the HeartBeam AIMIGo system, consists of a compact patient-worn device, a smartphone application, and cloud-based software that together provide comprehensive cardiac monitoring and analysis. The VECG technology synthesizes a 12-lead ECG equivalent from a simplified data collection approach, providing the diagnostic depth of traditional 12-lead ECGs without the complexity, cables, and electrodes required for conventional systems. This enables patients with known or suspected cardiovascular disease to record ECGs during symptoms and transmit them immediately to their healthcare providers for evaluation. The technology addresses critical needs in cardiac care including enabling earlier detection of heart attacks, reducing unnecessary emergency room visits, improving triage decisions, and facilitating remote monitoring of cardiac patients. HeartBeam has received FDA clearance for its technology and is focused on commercialization, reimbursement, and market development activities. The company is pursuing both direct-to-patient and healthcare system channels. HeartBeam competes in the growing cardiac monitoring market where mobile health technologies are increasingly used to improve access, convenience, and outcomes in cardiovascular care. The company's compact, cable-free approach and 12-lead output differentiate it from other mobile ECG solutions.